News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
334 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17894)
Month
January (3339)
February (3294)
March (4068)
April (3458)
May (4782)
June (3455)
July (2690)
August (3589)
September (3334)
October (3977)
November (4082)
December (2500)
Day
1 (201)
2 (268)
3 (272)
4 (305)
5 (108)
6 (6)
7 (10)
8 (235)
9 (334)
10 (239)
11 (333)
12 (116)
13 (2)
14 (3)
15 (255)
16 (204)
17 (173)
18 (167)
19 (88)
20 (9)
21 (8)
22 (183)
23 (215)
24 (191)
25 (218)
26 (104)
28 (2)
29 (12)
30 (225)
31 (296)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
28
29
30
31
Policy
BioCardia Announces US Patent on Bone Marrow Derived Neurokinin-1 Receptor Positive (NK1R+) Mesenchymal Stem Cells for Therapeutic Applications
BioCardia®, Inc. announces that the United States Patent Office has granted Patent Number 11,642,377.
May 9, 2023
·
4 min read
Business
HilleVax Announces Appointment of Nanette Cocero Ph.D., MBA, to its Board of Directors
HilleVax, Inc., a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines, announced the appointment of Nanette Cocero, Ph.D., MBA, to its Board of Directors, effective May 8, 2023.
May 9, 2023
·
2 min read
Business
uniQure Announces First Quarter 2023 Financial Results and Highlights Recent Company Progress
uniQure N.V., a leading gene therapy company advancing transformative therapies for patients with severe medical needs, reported its financial results for the first quarter of 2023 and highlighted recent progress across its business.
May 9, 2023
·
12 min read
Compugen to Present at the JMP Securities Life Sciences Conference - May 09, 2023
Compugen Ltd., a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, announced that management will present at the JMP Securities Life Sciences Conference, on Tuesday, May 16, 2023 at 9:00 AM ET.
May 9, 2023
·
1 min read
Bio NC
RedHill Publishes New Talicia® Data on Generic Non-Bioequivalence in AP&T and Presents New Dosing Data at Digestive Disease Week
RedHill Biopharma Ltd., a specialty biopharmaceutical company, announced two distinct sets of new Talicia[3] data focused on generic non-bioequivalence and on dosing regimens.
May 9, 2023
·
14 min read
Genetown
Ascidian Therapeutics to Present New Data From Its Lead Program Targeting ABCA4 Retinopathies at the ASGCT 2023 Annual Meeting
Ascidian Therapeutics announced that Head of Research Robert Bell, Ph.D., will present new data from its lead ABCA4 program at the Twenty-Sixth Annual Meeting of the American Society of Gene and Cell Therapy.
May 9, 2023
·
3 min read
Biotech Beach
Ionis to present at upcoming investor conferences - May 09, 2023
Ionis Pharmaceuticals, Inc. announced that management will participate in fireside chats at the following investor conferences.
May 9, 2023
·
1 min read
Business
bluebird bio Reports First Quarter 2023 Financial Results and Highlights Operational Progress
bluebird bio, Inc. reported financial results and business highlights for the first quarter ended March 31, 2023, including recent commercial and operational progress, and regulatory updates.
May 9, 2023
·
11 min read
Business
Assertio Reports First Quarter 2023 Financial Results, Raises Full Year 2023 Outlook
Assertio Holdings, Inc. today reported financial results for the first quarter ended March 31, 2023.
May 9, 2023
·
23 min read
Business
Mariana Oncology Expands Management Team, Appoints Linda Bain Chief Operating Officer and Chief Financial Officer
Mariana Oncology today announced the appointment of Linda Bain as Chief Operating Officer and Chief Financial Officer.
May 9, 2023
·
2 min read
Previous
14 of 34
Next